R&D News | pharmaphorum

News

OpenAI introduces GPT-Rosalind, its drug discovery AI

In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.

News

UK says it has hit target on commercial trial set-up times

The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in industry-backed studies.

News

Lift for UK healthtech as fund bags £100m from national bank

A new Apposite Capital fund has been set up with £100m to provide much-needed scale-up funding for UK biopharma and healthtech companies.

News

Lilly says Foundayo safety confirmed in ACHIEVE-4 trial

Eli Lilly's ACHIEVE-4 trial results for oral GLP-1 Foundayo set up a filing in diabetes, and provide safety data sought by the FDA.

News

Beeline raises $300m for BMS drugs, and other biofinancings

Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.

News

Novartis CEO joins board of "responsible" AI firm Anthropic

In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.

OpenAI introduces GPT-Rosalind, its drug discovery AI

UK says it has hit target on commercial trial set-up times

Lift for UK healthtech as fund bags £100m from national bank

Lilly says Foundayo safety confirmed in ACHIEVE-4 trial

Beeline raises $300m for BMS drugs, and other biofinancings

Novartis CEO joins board of "responsible" AI firm Anthropic

Trustworthy and novel AI in clinical trial planning, with Kr...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks